Envestnet Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,168
Closed -$295K 4720
2025
Q4
$295K Buy
7,168
+1,545
+27% +$61K ﹤0.01% 4050
2025
Q3
$209K Buy
+5,623
New +$204K ﹤0.01% 4299
2017
Q1
Sell
-15
Closed 3111
2016
Q4
$0 Buy
+15
New +$503 ﹤0.01% 3108

Other funds holding BME

Envestnet Asset Management's BME Position: Q1 2026 in Review

Envestnet Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q1 2026, closing a stake of 7,168 shares — an estimated $295K sold.

Envestnet Asset Management first reported a position in BME in Q4 2016 and held it in 3 quarters. The position peaked at $295K in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Envestnet Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q1 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 7,168 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $295K.
  • Envestnet Asset Management first reported a position in BlackRock Health Sciences Trust in Q4 2016 and held it in 3 quarters.
  • Envestnet Asset Management's BlackRock Health Sciences Trust position peaked at $295K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.